SuviCa

Business Services · Colorado, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

PO Box 3131, Boulder, Colorado, 80307, U...

Phone Number

(303) 921-6680

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About SuviCa

SuviCa, Inc. is dedicated to the discovery and development of small molecule cancer therapeutics, focusing on a unique mechanism of action. Founded in 2010, the company is currently advancing a small molecule protein synthesis inhibitor, SVC112, which is in pre-clinical development. SuviCa's innovative approach aims to address the limitations of existing cancer treatments by targeting cellular mechanisms critical for cancer re-growth, thereby offering potential for new combination therapies. Their intended clients include healthcare providers and patients seeking advanced cancer treatment options.Explore more
SuviCa's Social MediaPopular SearchesSuvica IncSuvica Int Autoparts IncSuviCaSIC Code 87,873NAICS Code 54,541Show more

SuviCa Org Chart

Judith Hemberger, Chief Executive Officer at SuviCa
United States flag for contact location.

Chief Executive Officer

PhoneEmail
WP
United States flag for contact location.

Chief Financial Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is SuviCa your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to SuviCa

Compare insights from companies similar to SuviCa, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

SuviCa

<$5M
1-10
Private
<$5M
2010
<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
2007
N/A
<$5M
1-10
Private
<$5M
2018
ER
Elizabeth RogersChief Operating Officer
<$5M
1-10
Private
-
2015
<$5M
1-10
Private
-
-
Mei Koh, Founder & Chief Executive Officer at Kuda Therapeutics
Mei KohFounder & CEO
11-50
Public
$199.6M
1996
James Caruso, President, Chief Executive Officer & Director at Cellectar Biosciences
James CarusoPresident, CEO & Director
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

SuviCa is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

SuviCa is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about SuviCa.

SuviCa financials insights

Gather financial insights about SuviCa, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2015

Grant

$1.5M

See All SuviCa's Financials Insights

SuviCa Tech Stack

A closer look at the technologies used by SuviCa

Top Business Services Companies

Frequently Asked Questions Regarding SuviCa

What is SuviCa's official website?
SuviCa's official website is www.suvica.com
What is SuviCa's Revenue?
SuviCa's revenue is <$5 Million
What is SuviCa's SIC code?
SuviCa's SIC: 87,873
What is SuviCa's NAICS code?
SuviCa's NAICS: 54,541
How many employees does SuviCa have?
SuviCa has 1-10 employees
What industry does SuviCa belong to?
SuviCa is in the industry of: Business Services, Research & Development
What is SuviCa competition?
SuviCa top competitors include: Accuronix Therapeutics, Go4cure, Frost Biologic, Gibson Oncology
What technology does SuviCa use?
Some of the popular technologies that SuviCa uses are: Google Workspace, Gmail
Who is the CFO of SuviCa?
SuviCa's CFO is Wendi Petro
How do I contact SuviCa?
SuviCa contact info: Phone number: (303) 921-6680 Website: www.suvica.com
What does SuviCa do?

SuviCa, Inc. is dedicated to the discovery and development of small molecule cancer therapeutics, focusing on a unique mechanism of action. Founded in 2010, the company is currently advancing a small molecule protein synthesis inhibitor, SVC112, which is in pre-clinical development. SuviCa's innovative approach aims to address the limitations of ex... isting cancer treatments by targeting cellular mechanisms critical for cancer re-growth, thereby offering potential for new combination therapies. Their intended clients include healthcare providers and patients seeking advanced cancer treatment options.Read More

What are SuviCa social media links?
SuviCa Linkedin page
Is SuviCa a public company?
SuviCa is private company therefore does not currently have an official ticker symbol
See more information about SuviCa

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.